These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

56 related items for PubMed ID: 8771533

  • 1. [3H]-SR 27897B: a selective probe for autoradiographic labelling of CCK-A receptors in the brain.
    Zajac JM, Gully D, Maffrand JP.
    J Recept Signal Transduct Res; 1996; 16(1-2):93-113. PubMed ID: 8771533
    [Abstract] [Full Text] [Related]

  • 2. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
    Durieux C, Ruiz-Gayo M, Corringer PJ, Bergeron F, Ducos B, Roques BP.
    Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.
    Chang RS, Chen TB, Bock MG, Freidinger RM, Chen R, Rosegay A, Lotti VJ.
    Mol Pharmacol; 1989 Jun; 35(6):803-8. PubMed ID: 2733696
    [Abstract] [Full Text] [Related]

  • 4. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
    Knapp RJ, Vaughn LK, Fang SN, Bogert CL, Yamamura MS, Hruby VJ, Yamamura HI.
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1278-86. PubMed ID: 2262906
    [Abstract] [Full Text] [Related]

  • 5. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
    Gigoux V, Maigret B, Escrieut C, Silvente-Poirot S, Bouisson M, Fehrentz JA, Moroder L, Gully D, Martinez J, Vaysse N, Fourmy AD.
    Protein Sci; 1999 Nov; 8(11):2347-54. PubMed ID: 10595537
    [Abstract] [Full Text] [Related]

  • 6. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies.
    Bignon E, Bachy A, Boigegrain R, Brodin R, Cottineau M, Gully D, Herbert JM, Keane P, Labie C, Molimard JC, Olliero D, Oury-Donat F, Petereau C, Prabonnaud V, Rockstroh MP, Schaeffer P, Servant O, Thurneyssen O, Soubrié P, Pascal M, Maffrand JP, Le Fur G.
    J Pharmacol Exp Ther; 1999 May; 289(2):742-51. PubMed ID: 10215648
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Contrasting roles of leu(356) in the human CCK(1) receptor for antagonist SR 27897 and agonist SR 146131 binding.
    Gouldson P, Legoux P, Carillon C, Delpech B, Le Fur G, Ferrara P, Shire D.
    Eur J Pharmacol; 1999 Nov 03; 383(3):339-46. PubMed ID: 10594328
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors.
    Rodriguez M, Lignon MF, Galas MC, Amblard M, Martinez J.
    Mol Pharmacol; 1990 Sep 03; 38(3):333-41. PubMed ID: 1698251
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the binding of [3H]-(+/-)-L-364,718: a new potent, nonpeptide cholecystokinin antagonist radioligand selective for peripheral receptors.
    Chang RS, Lotti VJ, Chen TB, Kunkel KA.
    Mol Pharmacol; 1986 Sep 03; 30(3):212-7. PubMed ID: 3018478
    [Abstract] [Full Text] [Related]

  • 13. Regional distribution of cholecystokinin receptors in macaque medial temporal lobe determined by in vitro receptor autoradiography.
    Kritzer MF, Innis RB, Goldman-Rakic PS.
    J Comp Neurol; 1988 Oct 08; 276(2):219-30. PubMed ID: 3220981
    [Abstract] [Full Text] [Related]

  • 14. Anatomical evidence for alpha-2 adrenoceptor heterogeneity: differential autoradiographic distributions of [3H]rauwolscine and [3H]idazoxan in rat brain.
    Boyajian CL, Loughlin SE, Leslie FM.
    J Pharmacol Exp Ther; 1987 Jun 08; 241(3):1079-91. PubMed ID: 3037066
    [Abstract] [Full Text] [Related]

  • 15. The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK(1) receptor.
    Gouldson P, Legoux P, Carillon C, Delpech B, Le Fur G, Ferrara P, Shire D.
    Eur J Pharmacol; 2000 Jul 21; 400(2-3):185-94. PubMed ID: 10988332
    [Abstract] [Full Text] [Related]

  • 16. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
    Zhou W, Povoski SP, Bell RH.
    J Surg Res; 1995 Mar 21; 58(3):281-9. PubMed ID: 7533864
    [Abstract] [Full Text] [Related]

  • 17. Autoradiographic study on [3H]-[D-Ala2]-deltorphin-I binding sites in the rat brain.
    Renda T, Negri L, Tooyama I, Casu C, Melchiorri P.
    Neuroreport; 1993 Sep 03; 4(10):1143-6. PubMed ID: 8219007
    [Abstract] [Full Text] [Related]

  • 18. Quantitative autoradiographic analysis of [3H]carfentanil binding to mu opiate receptors in the rat brain.
    Fitzgerald LW, Teitler M.
    Synapse; 1993 Jun 03; 14(2):154-9. PubMed ID: 8392757
    [Abstract] [Full Text] [Related]

  • 19. Development of high-affinity choline transport sites in rat forebrain: a quantitative autoradiography study with [3H]hemicholinium-3.
    Happe HK, Murrin LC.
    J Comp Neurol; 1992 Jul 22; 321(4):591-611. PubMed ID: 1506485
    [Abstract] [Full Text] [Related]

  • 20. CCK-X receptors in the endothermic mako shark (Isurus oxyrinchus).
    Oliver AS, Vigna SR.
    Gen Comp Endocrinol; 1996 Apr 22; 102(1):61-73. PubMed ID: 8860310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.